Kevin Mclaughlin - Oct 10, 2022 Form 4 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
Director
Signature
Jeffrey W. Schulz, Attorney-in-Fact
Stock symbol
DBTX
Transactions as of
Oct 10, 2022
Transactions value $
$0
Form type
4
Date filed
10/12/2022, 08:23 AM
Previous filing
Apr 29, 2022
Next filing
Apr 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +20K $0.00 20K Oct 10, 2022 Common Stock 20K $2.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 10, 2022 for 20,000 shares. The shares underlying the option vest in equal monthly installments until the third anniversary of the grant date, subject to the reporting person's continued service.